General Information of the Cell Line
Cell Line ID
CL000018
Cell Line Name
HL-60
Synonyms
HL 60
HL.60
HL60
Human Leukemia-60
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0002
Tissue Information
Peripheral blood
Disease
Adult acute myeloid leukemia (NCIt: C9154)
Acute myeloid leukemia (ORDO: Orphanet_519)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02529, 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase
Compound ID Compound Name Compound Formula
CP0472854
(1R,3aR,4R,5S,7aR)-5-[benzyl(methyl)amino]-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C27H45NO
 1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0530068
(1R,3aR,4R,5S,7aR)-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-5-[methyl(pent-4-enyl)amino]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C25H47NO
 1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0472862
(1R,3aR,4R,5S,7aR)-5-(benzylamino)-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C26H43NO
 1
1
IC50 = 8000 nM
   TI
   LI
   LO
   TS
CP0493822
(1R,3aR,4R,5S,7aR)-5-amino-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C19H37NO
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0418875
(1R,3aR,4R,5S,7aR)-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-5-(pent-4-enylamino)-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C24H45NO
 1
1
IC50 = 15000 nM
   TI
   LI
   LO
   TS
CP0481542
(1R,3aR,4R,5S,7aR)-5-(dimethylamino)-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C21H41NO
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0538319
(1R,3aR,4R,5S,7aR)-5-[benzyl(pent-4-enyl)amino]-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C31H51NO
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0410914
(1R,3aR,4R,5S,7aR)-5-(dibenzylamino)-3a,7a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7-hexahydro-1H-inden-4-ol
   Show/Hide
C33H49NO
 1
1
IC50 = 27000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0000040
CHEBI:23527
   Show/Hide
C29H37NO5  1
1
IC50 > 62549.51837 nM
   TI
   LI
   LO
   TS
CP0001250
(16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene
   Show/Hide
C23H24N4O  1
1
IC50 = 59 nM
   TI
   LI
   LO
   TS
CP0002967
N-[4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]phenyl]-1-[4-[[4-[4-(methanesulfonamido)phenyl]pyrimidin-2-yl]amino]phenyl]piperidine-4-carboxamide
   Show/Hide
C32H33N7O5S  1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3  1
1
IC50 = 2280 nM
   TI
   LI
   LO
   TS
CP0004666
1,3-dimethyl-N-(4-pyrrolidin-1-ylsulfonylphenyl)pyrazolo[4,3-e][1,2,4]triazin-5-amine
   Show/Hide
C16H19N7O2S  1
1
IC50 = 56000 nM
   TI
   LI
   LO
   TS
CP0005409
1,3-dimethyl-N-(4-morpholin-4-ylsulfonylphenyl)pyrazolo[4,3-e][1,2,4]triazin-5-amine
   Show/Hide
C16H19N7O3S  1
1
IC50 = 39000 nM
   TI
   LI
   LO
   TS
CP0007167
4-[(1,3-dimethylpyrazolo[4,3-e][1,2,4]triazin-5-yl)amino]-N-(2-morpholin-4-ylethyl)benzenesulfonamide
   Show/Hide
C18H24N8O3S  1
1
IC50 = 41000 nM
   TI
   LI
   LO
   TS
CP0007404
(E)-N-(2-amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide
   Show/Hide
C21H19FN4O  1
1
IG50 = 6100 nM
   TI
   LI
   LO
   TS
CP0007430
IBRUTINIB
   Show/Hide
C25H24N6O2  1
1
IC50 = 8000 nM
   TI
   LI
   LO
   TS
CP0008251
N-(2-aminophenyl)-4-[[(2E)-3-(3-bromo-4-hydroxyphenyl)-2-hydroxyiminopropanoyl]amino]butanamide
   Show/Hide
C19H21BrN4O4  1
1
IG50 > 40000 nM
   TI
   LI
   LO
   TS
CP0009043
N-[4-[4-[(2S,4aS,6aR,6aS,6bR,8aR,12aS,14bR)-11-cyano-2,4a,6a,6b,9,9,12a-heptamethyl-10,13-dioxo-1,3,4,5,6,6a,7,8,8a,14b-decahydropicene-2-carbonyl]piperazin-1-yl]phenyl]-N'-hydroxyoctanediamide
   Show/Hide
C49H67N5O6  1
1
IC50 = 370 nM
   TI
   LI
   LO
   TS
CP0009098
(2E)-N-[3-(2-aminoanilino)-3-oxopropyl]-3-(3-bromo-4-hydroxyphenyl)-2-hydroxyiminopropanamide
   Show/Hide
C18H19BrN4O4  1
1
IG50 > 40000 nM
   TI
   LI
   LO
   TS
CP0010193
AG-013736
   Show/Hide
C22H18N4OS  1
1
GI50 = 6780 nM
   TI
   LI
   LO
   TS
CP0013015
N-[4-(2-oxo-8-pyridin-3-yl-[1]benzofuro[3,2-b]pyridin-1-yl)phenyl]prop-2-enamide
   Show/Hide
C25H17N3O3  1
1
IC50 = 4200 nM
   TI
   LI
   LO
   TS
CP0013313
N-(2-aminophenyl)-7-[[(2E)-3-(3-bromo-4-hydroxyphenyl)-2-hydroxyiminopropanoyl]amino]heptanamide
   Show/Hide
C22H27BrN4O4  1
1
IG50 = 14000 nM
   TI
   LI
   LO
   TS
CP0014643
(2E)-3-(3-bromo-4-hydroxyphenyl)-N-butyl-2-hydroxyiminopropanamide
   Show/Hide
C13H17BrN2O3  1
1
GI50 = 36000 nM
   TI
   LI
   LO
   TS
CP0014644
(2E)-3-(3-bromo-4-hydroxyphenyl)-2-hydroxyimino-N-propylpropanamide
   Show/Hide
C12H15BrN2O3  1
1
GI50 = 13500 nM
   TI
   LI
   LO
   TS
CP0017985
N-[4-[8-(6-methoxypyridin-3-yl)-2-oxo-[1]benzofuro[3,2-b]pyridin-1-yl]phenyl]-2-piperidin-1-ylacetamide
   Show/Hide
C30H28N4O4  1
1
IC50 = 4900 nM
   TI
   LI
   LO
   TS
CP0029123
N-[4-[8-(6-methoxypyridin-3-yl)-2-oxo-[1]benzofuro[3,2-b]pyridin-1-yl]phenyl]-2-pyrrolidin-1-ylacetamide
   Show/Hide
C29H26N4O4  1
1
IC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0030740
1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morpholin-4-Yl)ethoxy]imidazo[2,1-B][1,3]benzothiazol-2-Yl}phenyl)urea
   Show/Hide
C29H32N6O4S  1
1
GI50 = 130 nM
   TI
   LI
   LO
   TS
CP0031672
N-[4-[8-(6-methoxypyridin-3-yl)-2-oxo-[1]benzofuro[3,2-b]pyridin-1-yl]phenyl]-2-morpholin-4-ylacetamide
   Show/Hide
C29H26N4O5  1
1
IC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3  1
1
IC50 = 54500 nM
   TI
   LI
   LO
   TS
CP0037780
(2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid
   Show/Hide
C16H24N2O4  1
1
IC50 = 1340000 nM
   TI
   LI
   LO
   TS
CP0069522
Alinia
   Show/Hide
C12H9N3O5S  1
1
IC50 = 20100 nM
   TI
   LI
   LO
   TS
CP0083691
2-(4-fluorophenyl)-[1,2]thiazolo[5,4-b]pyridin-3-one
   Show/Hide
C12H7FN2OS  1
1
GI50 = 3420 nM
   TI
   LI
   LO
   TS
CP0084994
(2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine;hydrochloride
   Show/Hide
C29H40N2O4  1
1
IC50 = 790.5960678 nM
   TI
   LI
   LO
   TS
CP0124683
(E)-4-(3,5-dimethoxystyryl)phenol
   Show/Hide
C16H16O3  1
1
IC50 = 35000 nM
   TI
   LI
   LO
   TS
CP0164979
1-[4-(4-amino-7-prop-2-enylpyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea
   Show/Hide
C23H25N7O2  1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0181158
[(1R,3R,4R,5R,7S,8R,9R,10E,12S,13S,14S)-4,13-diacetyloxy-10-(hydroxymethyl)-8-methoxy-3,6,6,14-tetramethyl-2-oxo-16-oxatetracyclo[10.3.1.01,12.05,7]hexadec-10-en-9-yl] (Z)-2-methylbut-2-enoate
   Show/Hide
C30H42O10  1
1
IC50 < 10000 nM
   TI
   LI
   LO
   TS
CP0187002
(3,4-DICHLOROPHENYL)(MORPHOLINO)METHANETHIONE
   Show/Hide
C11H11Cl2NOS  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0193520
1-[5-(4-fluorophenyl)-2-(3-hydroxy-4-methoxyphenyl)-2H-1,3,4-oxadiazol-3-yl]ethanone
   Show/Hide
C17H15FN2O4  1
1
IC50 = 60547.34803 nM
   TI
   LI
   LO
   TS
CP0193522
N-[(E)-(5-bromothiophen-2-yl)methylideneamino]-4-fluorobenzamide
   Show/Hide
C12H8BrFN2OS  1
1
IC50 = 48902.74467 nM
   TI
   LI
   LO
   TS
CP0239758
1-[5-(4-fluorophenyl)-2-phenyl-2H-1,3,4-oxadiazol-3-yl]ethanone
   Show/Hide
C16H13FN2O2  1
1
IC50 = 110098.8427 nM
   TI
   LI
   LO
   TS
CP0252873
(4R)-4-[(1S,2R,5S,10S,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl]-N,N-dimethylpentanamide
   Show/Hide
C26H43NO2  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0271917
(2R)-N-[(2S,3S)-2-amino-3-hydroxy-3-(4-nitrophenyl)propyl]-2-[[(2S)-3-amino-2-hydroxypropanoyl]amino]-3-phenylpropanamide
   Show/Hide
C21H27N5O6  1
1
IC50 = 2040000 nM
   TI
   LI
   LO
   TS
CP0271918
(2S)-2-amino-N-[(2R)-1-[[(2S,3S)-2-amino-3-(4-aminophenyl)-3-hydroxypropyl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpentanamide
   Show/Hide
C24H35N5O3  1
1
IC50 = 1550000 nM
   TI
   LI
   LO
   TS
CP0285857
4-fluoro-N-[(E)-furan-2-ylmethylideneamino]benzamide
   Show/Hide
C12H9FN2O2  1
1
IC50 = 116274.0623 nM
   TI
   LI
   LO
   TS
CP0315362
N'-hydroxy-N-[4-[3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propylamino]phenyl]octanediamide
   Show/Hide
C26H32N8O3  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0320291
3-(benzotriazol-1-ylmethyl)-6-(3-fluorophenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
   Show/Hide
C16H10FN7S  1
1
IC50 > 200000 nM
   TI
   LI
   LO
   TS
CP0335215
4-(5-ethylsulfonyl-2-methoxyphenyl)-2- methyl-6-(1-methylpyrazol-4-yl)isoquinolin- 1-one
   Show/Hide
C23H23N3O4S  1
1
IC50 = 45 nM
   TI
   LI
   LO
   TS
CP0374518
CHEBI:3533
   Show/Hide
C28H38N2O4  1
1
IC50 = 31931.76461 nM
   TI
   LI
   LO
   TS
CP0376090
4-[(E)-2-(3,5-dimethoxy-phenyl)-vinyl]-2,6-dimethoxy-phenol
   Show/Hide
C18H20O5  1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0383413
N-[2-methyl-5-(2-oxo-9-pyrazol-1-ylbenzo[h][1,6]naphthyridin-1-yl)phenyl]prop-2-enamide
   Show/Hide
C25H19N5O2  1
1
GI50 = 3800 nM
   TI
   LI
   LO
   TS
CP0383415
N-[2-methyl-5-(2-oxo-9-pyrazol-1-ylbenzo[h][1,6]naphthyridin-1-yl)phenyl]propanamide
   Show/Hide
C25H21N5O2  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CP0390331
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C24H38O3  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0391821
(Z)-3,4,3'',5''-Tetramethoxystilbene
   Show/Hide
C18H20O4  1
1
IC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0396688
[(1R)-1-[[(2S)-2-[(3,4-difluorophenyl)methylcarbamoylamino]-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid
   Show/Hide
C22H28BF2N3O4  1
1
IC50 = 28.53 nM
   TI
   LI
   LO
   TS
CP0404729
4-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-2-N-[(3-fluorophenyl)methyl]-6-(2,3,4,5,6-pentafluorophenoxy)-1,3,5-triazine-2,4-diamine
   Show/Hide
C22H22F6N6O3  1
1
IC50 = 15000 nM
   TI
   LI
   LO
   TS
CP0408205
2-[(E)-2-(3,5-dimethoxyphenyl)vinyl]-6-methoxyphenol
   Show/Hide
C17H18O4  1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0413319
1-(3-chlorophenyl)-2-morpholin-4-yl-2-sulfanylideneethanone
   Show/Hide
C12H12ClNO2S  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0413322
1-(4-bromophenyl)-2-morpholin-4-yl-2-sulfanylideneethanone
   Show/Hide
C12H12BrNO2S  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0416813
N-(3-ethynylphenyl)-2-hydroxy-5-[7-(hydroxyamino)-7-oxoheptoxy]benzamide
   Show/Hide
C22H24N2O5  1
1
IC50 = 30900 nM
   TI
   LI
   LO
   TS
CP0419733
4,3'',5''-trimethoxy-[1,1';3',1'']-terphenyl
   Show/Hide
C21H20O3  1
1
IC50 = 50000 nM
   TI
   LI
   LO
   TS
CP0421635
N-(5-nitro-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide
   Show/Hide
C11H6F3N3O3S  1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0436560
3'',5''-dimethoxy-[1,1';4,1'']-terphenyl-4-ol
   Show/Hide
C20H18O3  1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
CP0436915
5-[4-(4-hydroxyphenyl)phenyl]benzene-1,3-diol
   Show/Hide
C18H14O3  1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0441876
3-[(E)-2-(3,5-Dimethoxy-phenyl)-vinyl]-phenol
   Show/Hide
C16H16O3  1
1
IC50 = 23000 nM
   TI
   LI
   LO
   TS
CP0451875
6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol
   Show/Hide
C18H16O3  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0455669
4,3'',5''-trimethoxy-[1,1';4',1'']-terphenyl
   Show/Hide
C21H20O3  1
1
IC50 = 75000 nM
   TI
   LI
   LO
   TS
CP0472278
1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[1-[2-chloro-4-(2-morpholin-4-ylethoxy)phenyl]triazol-4-yl]phenyl]urea
   Show/Hide
C28H32ClN7O4  1
1
GI50 > 3000 nM
   TI
   LI
   LO
   TS
CP0476635
(E)-N-hydroxy-3-[4-[3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propylamino]phenyl]prop-2-enamide
   Show/Hide
C21H21N7O2  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0480410
2-({4-[(2,4-Diamino-pyrido[2,3-d]pyrimidin-6-ylmethyl)-amino]-5,6,7,8-tetrahydro-naphthalene-1-carbonyl}-amino)-pentanedioic acid
   Show/Hide
C24H27N7O5  1
1
IC50 = 17 nM
   TI
   LI
   LO
   TS
CP0481473
1-(4-chlorophenyl)-2-morpholin-4-yl-2-sulfanylideneethanone
   Show/Hide
C12H12ClNO2S  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0483584
1-(2-chlorophenyl)-2-morpholin-4-yl-2-sulfanylideneethanone
   Show/Hide
C12H12ClNO2S  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0485450
(2S)-1-[(2S)-2-(butanoylamino)-3-methylbutanoyl]-N-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[methyl-[(2S)-3-methyl-1-[methyl(1,3-thiazol-2-ylmethyl)amino]-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C41H63N7O6S  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0489768
N-[3-[(3-ethynylphenyl)carbamoyl]-4-hydroxyphenyl]-N'-hydroxyheptanediamide
   Show/Hide
C22H23N3O5  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0489769
N-[3-[(3,4-dichlorophenyl)carbamoyl]-4-hydroxyphenyl]-N'-hydroxyheptanediamide
   Show/Hide
C20H21Cl2N3O5  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0492769
4-chloro-N-(2-nitrophenyl)benzamide
   Show/Hide
C13H9ClN2O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0494085
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-aminopropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C24H39NO2  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0520003
[(3S,5S,9R,10S,13R,14R,17R)-17-[(2S)-1-formyloxypropan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
   Show/Hide
C25H38O4  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0527717
2-chloro-1-[2,4-diamino-6-[2-(4-fluorophenyl)ethyl]-7,8-dihydro-6H-pyrido[3,2-d]pyrimidin-5-yl]ethanone
   Show/Hide
C17H19ClFN5O  1
1
IC50 = 790 nM
   TI
   LI
   LO
   TS
CP0533913
3-[4-amino-3-(1H-indol-3-yl)pyrazolo[3,4-d]pyrimidin-1-yl]-2,2-dimethylpropan-1-ol
   Show/Hide
C18H20N6O  1
1
IC50 = 27600 nM
   TI
   LI
   LO
   TS
CP0553019
2-chloro-1-[2,4-diamino-6-[2-(4-methylphenyl)ethyl]-7,8-dihydro-6H-pyrido[3,2-d]pyrimidin-5-yl]ethanone
   Show/Hide
C18H22ClN5O  1
1
IC50 = 390 nM
   TI
   LI
   LO
   TS
CP0943220
11-(3-(dimethylamino)propylamino)-7-fluoro-5-methyl-10H-indolo[3,2-b]quinolin-5-ium iodide
   Show/Hide
C21H24FIN4  1
1
IC50 = 1210 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6 Homo sapiens (Human) Adult acute monocytic leukemia
MOLM-13 Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2 Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14 Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1 Homo sapiens (Human) Childhood acute monocytic leukemia
MV4-11 Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue Homo sapiens (Human) Childhood acute monocytic leukemia
SEM Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
Jurkat E6.1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-CEM Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
EoL-1 Homo sapiens (Human) Chronic eosinophilic leukemia, not otherwise specified
CII Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL Homo sapiens (Human) Erythroleukemia
UKE-1 Homo sapiens (Human) Essential thrombocythemia
L-1236 Homo sapiens (Human) Hodgkin lymphoma
Granta-519 Homo sapiens (Human) Mantle cell lymphoma
JeKo-1 Homo sapiens (Human) Mantle cell lymphoma
Mino Homo sapiens (Human) Mantle cell lymphoma
HMC-1 Homo sapiens (Human) Mast cell leukemia
NK-92 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
RPMI-8226 Homo sapiens (Human) Plasma cell myeloma
OPM-2 Homo sapiens (Human) Plasma cell myeloma
U266B1 Homo sapiens (Human) Plasma cell myeloma
KMS-18 Homo sapiens (Human) Plasma cell myeloma
MM1.S Homo sapiens (Human) Plasma cell myeloma
MM1.R Homo sapiens (Human) Plasma cell myeloma
OPM-1 Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40 Homo sapiens (Human) Plasma cell myeloma
HuT 78 Homo sapiens (Human) Sezary syndrome
H9 Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1 Homo sapiens (Human) Sickle cell disease
RBL-1 Rattus norvegicus (Rat) Rat leukemia
RBL-2H3 Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28 Homo sapiens (Human) -
JY Homo sapiens (Human) -
C.M.L. Homo sapiens (Human) -
BON Homo sapiens (Human) -
PBMC iPSC #1 Homo sapiens (Human) -
LCL 721 Homo sapiens (Human) -